Your browser doesn't support javascript.
A call to action: Community pharmacists to address COVID-19-related behavioral health concerns.
J Am Pharm Assoc (2003) ; 61(3): e75-e77, 2021.
Article in English | MEDLINE | ID: covidwho-1272512
ABSTRACT
Owing to the extended nature and worldwide exposure of the coronavirus disease (COVID-19) pandemic, it is likely that the presence and impact of behavioral health conditions will increase. For example, it is anticipated that individuals living with a major depressive disorder could reach as high as 60% of the population owing to the ongoing disruption from COVID-19. In 2017, the annual rate of individuals experiencing a major depressive episode was only 7.1%. Pharmacists, specifically community pharmacists, are well positioned to provide needed intervention and triage services to individuals living with, and struggling with, a mental health condition. Pharmacists, therefore, need additional training and support to be effective in serving the community in this way.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Depressive Disorder, Major / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Am Pharm Assoc (2003) Journal subject: Pharmacy Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Depressive Disorder, Major / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: J Am Pharm Assoc (2003) Journal subject: Pharmacy Year: 2021 Document Type: Article